The deletion of exon 52 of the DMD gene, a mutation frequently present in humans, through a targeted replacement of exon 52 with a neomycin resistance cassette (neo®), led to the generation of DMD∆52 pigs with typical signs of DMD, including mobility impairment and severe myopathy [43]. The gene discussed is DMD; the disease is myopathy.